CASI Pharmaceuticals CASI

$ 2.65 -5.02%

Quarterly report 2022-Q3
added 11-14-2022

CASI Pharmaceuticals Total Liabilities 2011-2024 | CASI

Annual Total Liabilities CASI Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30.3 M	46.2 M	29.6 M	3.95 M	6.56 M	6.93 M	11.9 M	11.7 M	565 K	743 K	704 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
46.2 M	565 K	13.6 M

Quarterly Total Liabilities CASI Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	44.7 M	29.3 M	30.8 M	30.3 M	26.8 M	27 M	25.9 M	24.2 M	24.2 M	24.2 M	24.2 M	8.97 M	8.97 M	8.97 M	8.97 M	3.95 M	3.95 M	3.95 M	3.95 M	6.56 M	6.56 M	6.56 M	6.56 M	6.93 M	6.93 M	6.93 M	6.93 M	11.9 M	11.9 M	11.9 M	11.9 M	11.7 M	11.7 M	11.7 M	11.7 M	565 K	565 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
44.7 M	565 K	13.9 M